The Society of Hematologic Oncology (SOHO) Annual Meeting 2020, 9-12 September, will see hematology experts from around the world congregate virtually to communicate high-quality content focusing on the latest information for practitioners and scientists in the field.

Highlights from this year’s SOHO Annual Meeting include clinical updates on leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas and other related malignancies.

View all videos

SOHO 2020

Society of Hematologic Oncology (SOHO) Annual Meeting 2020
09–12 September 2020 | Houston, Texas, USA

In advance of our 2nd debate at #iwCLL2021 between Peter Dreger and @drjgauthier, which type of cellular therapy do you prefer for your patients with CLL?

Very nice description of a very difficult clinical situation: Richter’s Transformation with CNS involvement. Presented by @YucaiWangMD @WeiDing3 at #iwCLL2021

How would you treat a fit patient with clonally related Richter Transformation (no active CLL) with systemic and parenchymal CNS involvement? #LymSM #lymphoma #iwCLL2021

Barbara Eichorst of @UKKoeln talks on the mechanisms and predictive markers of drug resistance in CLL at the #iwCLL2021 meeting 👩‍⚕️🔬

Watch now 👉http://ow.ly/DGxp50GbUlC👈

@VJHemOnc @iwCLL #CLLsm #LEUsm #Leukemia #HemOnc

Great talk on bispecific antibodies by Adrian Wiestner at the #iwCLL2021 meeting! 👨‍⚕️💉

Watch interviews with CLL experts here 👉http://ow.ly/vyi850GbSPz👈

@VJHemOnc @iwCLL #CLLsm #LEUsm #Leukemia

3
Load More...

SOHO 2020

Society of Hematologic Oncology (SOHO) Annual Meeting 2020
09–12 September 2020 | Houston, Texas, USA

The Society of Hematologic Oncology (SOHO) Annual Meeting 2020, 9-12 September, will see hematology experts from around the world congregate virtually to communicate high-quality content focusing on the latest information for practitioners and scientists in the field.

Highlights from this year’s SOHO Annual Meeting include clinical updates on leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas and other related malignancies.

View all videos

In advance of our 2nd debate at #iwCLL2021 between Peter Dreger and @drjgauthier, which type of cellular therapy do you prefer for your patients with CLL?

Very nice description of a very difficult clinical situation: Richter’s Transformation with CNS involvement. Presented by @YucaiWangMD @WeiDing3 at #iwCLL2021

How would you treat a fit patient with clonally related Richter Transformation (no active CLL) with systemic and parenchymal CNS involvement? #LymSM #lymphoma #iwCLL2021

Barbara Eichorst of @UKKoeln talks on the mechanisms and predictive markers of drug resistance in CLL at the #iwCLL2021 meeting 👩‍⚕️🔬

Watch now 👉http://ow.ly/DGxp50GbUlC👈

@VJHemOnc @iwCLL #CLLsm #LEUsm #Leukemia #HemOnc

Great talk on bispecific antibodies by Adrian Wiestner at the #iwCLL2021 meeting! 👨‍⚕️💉

Watch interviews with CLL experts here 👉http://ow.ly/vyi850GbSPz👈

@VJHemOnc @iwCLL #CLLsm #LEUsm #Leukemia

3
Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter